-
DailyClout Makes Legislation Easy to Understand, Share and Act Upon
Join the CommunitySearch BillCam
-
LET'S SAVEDEMOCRACYTOGETHER
July 21, 2022
Melanie Brown, Team 4
Report 34: Understanding C-19 Vaccine Efficacy Clinical Trial in Lay Terms
The Moderna vaccine decreases the production of antibodies to the nucleocapsid in a dose dependent fashion in those who acquire COVID after vaccination. Four months after injection, 40% of vaccinated participants who acquired COVID after the second injection produced antibodies to the nucleocapsid, compared to 93% of those who received …
July 21, 2022
DailyClout
President Biden Has Just Tested Positive For COVID-19 – Breaking News
President Joe Biden has tested positive for COVID this morning and is reportedly experiencing mild symptoms. He is isolating at the White House. See Full Story
July 21, 2022
No College Mandates
Our Letter to NCAA President Mark Emmert: Investigate Harms Caused by C-19 Shot Mandates
Mandates cause student athletes harm and discrimination On June 30, No College Mandates sent the letter below to NCAA President Mark Emmert. We asked Mr. Emmert and the NCAA to investigate the negative impact on collegiate athletes resulting from Covid-19 vaccination mandates at more than 1,000 colleges. A copy of …
July 19, 2022
Kate Melgoza, No Interruptions
Kate Melgoza Reacts to Vaccine Hesitancy “Propaganda” – Video
In this video, Kate Melgoza reacts to PA Against Covid’s “resource library,” where visitors can study the guidelines for convincing friends and family members to get the Covid vaccine. Is describing cautions individuals “vaccine hesitant” propaganda? How is encouraging those who have submitted to the vaccine narrative to turn on …
July 19, 2022
Linnea Wahl, Team 5
Report 33: Pfizer’s New Two-in-One COVID-19 Booster: Are We the Clinical Trial?
Most important finding: Pfizer’s planned bivalent booster vaccines will not be tested for safety or effectiveness before they are rolled out to the public this fall. Key detail leading to finding: Pfizer’s fall 2022 booster will be formulated to respond to two extinct or nearly extinct strains of SARS-CoV-2, may …